The Catalyst Contributors
Authors Contributing to The Catalyst
The Catalyst provides news and commentary on access to life-saving treatments, America’s biopharma industry and researchers’ progress in developing new medicines.
The Catalyst is edited by Kaelan Hollon , Senior Director of Communications at PhRMA. Contributors include PhRMA staff and leaders from the industry.
John Castellani 
In August 2010, Mr. Castellani joined PhRMA, which represents America’s leading pharmaceutical research and biotechnology companies. In assuming his new responsibilities, Mr. Castellani pledged PhRMA will continue to lead efforts to find patient-centered solutions to healthcare challenges in America and around the globe. Read more .
Jon Tripp 
Jon Tripp is Senior Director of Digital Advocacy in the Communications & Public Affairs department at PhRMA where he oversees the organization’s widespread online presence. He came to PhRMA in 2005 after serving as Deputy Communications Director for the U.S. House of Representatives Committee on Energy and Commerce. Read more .
Follow Jon on Twitter @JonAtPhRMA 
Stephanie recently joined PhRMA’s communications team after nearly eight years with a biotech trade association. Prior to that, she was the Communications Director for her local Congressman from Bucks County, Pennsylvania. Read more .
Follow Stephanie on Twitter @SDFatPhRMA 
Matt Bennett 
Matt Bennett is the Senior Vice President of Communications at PhRMA. He is also a die hard Red Sox fan. Read more. 
Follow him on Twitter @mattdbennett 
Sascha Haverfield, Ph.D., is Vice President of Scientific and Regulatory Affairs at PhRMA. Read more .
Randy Burkholder 
Randy Burkholder is Deputy Vice President of Policy at the Pharmaceutical Research and Manufacturers of America. Read more .
Jenni Brewer 
Jenni Brewer came to PhRMA with nearly a decade of colorful public affairs experience. Her work pursuits have landed her in turkey farms, NASCAR races, and even a Civil War fort. Read more .
Bill Chin 
Dr. Bill Chin leads PhRMA’s Scientific & Regulatory Affairs department. A physican, an endocrinologist and an academic at heart, Dr. Chin is envisions establishing PhRMA as the premiere convener in advancing drug discovery and development, regulatory sciences and collaborative partnerships. Read more. 
Christian Clymer 
Christian has been a member of the PhRMA family for 12 years. In that time, he has helped create programs to assist the uninsured and promote the value of innovative jobs. Read more .
Follow Christian on Twitter @CCatPhRMA 
Grady Forrer 
Grady Forrer has been communicating about health care, science, public affairs and technological innovation for nearly 20 years. Grady started his career as an investigator for a Congressional Subcommittee. Read more .
Follow Grady on Twitter @GradyAtPhRMA 
Kaelan Hollon 
Kaelan Hollon joined PhRMA in 2007, coming from a public relations firm in Louisville, Kentucky. She previously worked for a small law firm that handled bioethics consulting, and while in Louisville she managed several health care accounts for lobbying and public affairs clients. Read more .
Follow Kaelan on Twitter @KaelanAtPhRMA 
Jeff Trewhitt 
Jeff Trewhitt is a 23-year PhRMA veteran and two-time cancer survivor who understands at both personal and professional levels the importance of sustaining the world-leading innovation of America’s biopharmaceutical research companies. Read more .
Karl Uhlendorf 
Karl Uhlendorf joined PhRMA more than five years ago, making the valiant leap from journalism to communications. He spent the previous 13 years at Elsevier/FDC Reports, covering the regulatory, policy and business environments impacting the biopharma, med device and consumer health sectors. Read more . 
Follow Karl on Twitter @KUhlendorf 
Josie Martin 
Josie Martin is Executive Vice President of Public Affairs at PhRMA. Read more .
Jennifer Wall 
Nearly seven years ago, Jennifer Wall left Capitol Hill and started doing media advocacy for PhRMA. After invaluable experience while working as a communications staffer for the Homeland Security Committee and Speaker of the House, she decided to venture into new territory and explore other issues of interest to the country – biopharmaceuticals, innovation, and healthcare policy. Read more .
Follow Jennifer on Twitter @JenAtPhRMA 
Preet Bilinski 
Preet Bilinski arrived at PhRMA nine years ago, after graduating from James Madison University. Somehow her degree in Computer Information Systems landed her in the healthcare communications world. She manages the Medicines in Development series, that showcases the hope and promise of innovative treatments. In her spare time, she’s trying to keep her puppy, Jake from eating her out of house and home. Read more .
Follow Preet on Twitter @PreetAtPhRMA 
Salvatore Alesci 
Salvatore (“Salvo”) Alesci, M.D., Ph.D. joined PhRMA in December 2011 as Vice President, Scientific Affairs. In this role, Dr. Alesci serves as the primary expert for PhRMA on scientific and medical issues. He carries overall responsibility for establishing PhRMA as a “go to” source for input on policies and legislation related to innovative approaches to biopharmaceutical discovery and development. Dr. Alesci brings to PhRMA over ten years of combined academia/government/industry research experience and multi-disciplinary expertise in Translational Medicine.
Rick Smith 
Richard I. Smith is a past Executive Vice President for Policy and Research at the Pharmaceutical Research and Manufacturers of America (PhRMA).
Previously, Rick was Vice President, Public Policy and Research at the American Association of Health Plans; Vice President, Health Policy at the Association of Private Pension and Welfare Plans (now the American Benefits Council); Director, Public Policy at the Washington Business Group on Health (now the National Business Group on Health); and Staff Director of the Maryland Governor’s Commission on Health Care Policy and Financing. Read more .
Daniel Seaton 
Daniel Seaton joined PhRMA in 2009 after relocating to DC from his native New Mexico. He has a degree in Liberal Arts from Thomas Aquinas College in California, and really misses the beach weather. He is currently pursuing a Master’s degree in communications at Georgetown. In his spare time, he enjoys hiking and volunteering as an ESL tutor. Read more. 
Chip Davis 
Chester “Chip” Davis, Jr. currently serves as Executive Vice President for Advocacy at PhRMA. In this role Davis is responsible for leading and managing PhRMA’s federal, state and international government relations and advocacy efforts. Read more. 
K ristin Van Goor
Kristin is a Senior Director of Scientific and Regulatory Affairs at PhRMA. She leads PhRMA's activities on regulatory and science policy issues ranging from innovative biologics and biosimilars, information technology, benefit-risk assessment, and patient-focused drug development. Read more. 
Brian Reid 
Brian Reid serves as Director of WCG specializing in life science communications, particularly surrounding media, regulatory action, and new media. He was a longtime Washington D.C. journalist, covering health science for Bloomberg News. Read more .
Follow Brian on Twitter @brianreid